ENSP has launched the second Series of Fact Sheets covering a range of tobacco control topics. The latest 3 editions are dedicated to Tobacco Taxation, Emerging and Novel Tobacco Products and Impact of novel and emerging products AND youth.
Context: the tobacco epidemic in Europe
High prevalence: Compared to the rest of the world, the WHO Europe Region has the highest prevalence of tobacco smoking adults and among the highest smoking rates among adolescents.
High costs: Direct health costs: Tobacco-related disease
Indirect costs: Premature death, disability due to disease, decreased productivity
High morbidity and mortality: Tobacco use is estimated to be responsible for 16% of all deaths in adults above the age of 30 in the WHO Europe Region and a major contributor to socioeconomic disparity.
What are ‘novel tobacco products’?
According to the EU Tobacco Products Directive (2014/40/EU), a ‘novel tobacco product’ is defined as a tobacco product which does not fall into any of the following categories: cigarettes, roll-you-own tobacco, pipe tobacco, waterpipe tobacco, cigars, cigarillos, chewing tobacco, nasal tobacco or tobacco for oral use ; and was placed on the market after 19 May 2014.
Context: Secondhand Aerosol (SHA)
“A new smoking ban law without any exception under immediate enforcement” As of November 19th, 2019, the new Greek Smoking Ban Law is coming into force broadly to all closed...
The European Network for Smoking and Tobacco Prevention invites interested and experienced candidates to apply for the position as External Evaluator to carry out an external evaluation of activities...
Tackling tobacco-related chronic diseases in Europe: Novel data from the Horizon 2020 TackSHS project reveals the results of exposure to secondhand smoke (SHS) from cigarettes and second-hand aerosols (SHA) from...